Form 4: Danaher CFO Receives Significant Equity Grants

Danaher's EVP & CFO Matthew Gugino was granted restricted stock units and stock options as part of his compensation package.

Summary

• Matthew E. Gugino, Executive Vice President and Chief Financial Officer of Danaher Corporation, reported equity transactions on March 1, 2026.
• Gugino was granted 3,988 restricted stock units (RSUs) which are payable solely in common stock and vest 25% on each of the first four anniversaries of the grant date.
• He also received 10,778 employee stock options with an exercise price of $210.64, which become exercisable 50% on the third and fourth anniversaries of the March 1, 2026 grant date and expire on March 1, 2036.
• A disposition of 231 shares of common stock occurred at a price of $210.64, likely for tax withholding purposes related to the equity compensation.
• Following these transactions, Gugino directly owns 11,401 shares of common stock and indirectly owns 112.137 shares through a 401(k) plan, in addition to the 10,778 stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive, routine filing. The equity grants align executive interests with shareholders, which is generally favorable, but it does not introduce new material information to significantly alter the company's investment profile.

Positives

• The grant of 3,988 restricted stock units and 10,778 employee stock options aligns the executive's long-term interests with those of shareholders.
• The multi-year vesting schedules for both RSUs (25% annually over four years) and options (50% on third and fourth anniversaries) incentivize sustained performance and retention of key management.

Negatives

• A disposition of 231 shares of common stock at $210.64 was reported, which is a common practice for covering tax obligations associated with equity compensation and does not indicate a negative outlook.

Future Outlook

The filing details future vesting schedules for restricted stock units and stock options, indicating a long-term incentive structure for the EVP & Chief Financial Officer. No forward-looking statements regarding company performance or financial guidance are provided.

Industry Context

StockSavvy.ai notes that executive equity grants, including restricted stock units and stock options with multi-year vesting schedules, are a standard practice across industries, particularly for large-cap companies. This approach is widely adopted to align the interests of key management with long-term shareholder value creation and to incentivize executive retention and performance.

Comparison to Industry Standards

• StockSavvy.ai notes that equity compensation, including RSUs and stock options with multi-year vesting schedules, is a standard practice among large-cap companies like Danaher.
• This compensation structure is comparable to practices at industry peers such as Thermo Fisher Scientific (TMO) or Abbott Laboratories (ABT), which also utilize performance-based equity to incentivize long-term executive performance and align management with shareholder interests.

Related Party Transactions

• The reported transactions involve the grant of equity compensation (restricted stock units and stock options) to Matthew E. Gugino, the EVP & Chief Financial Officer, which is a standard form of executive compensation.

Stakeholder Impact

• Shareholders benefit from the increased alignment of executive incentives with long-term company performance through equity grants, potentially leading to better strategic decisions and sustained growth.
• The EVP & Chief Financial Officer receives significant compensation, which can enhance retention and motivation, contributing to stable leadership.

Next Steps

• Vesting of 25% of the 3,988 restricted stock units on each of the first four anniversaries of March 1, 2026.
• Vesting of 50% of the 10,778 employee stock options on the third anniversary of March 1, 2026.
• Vesting of the remaining 50% of the 10,778 employee stock options on the fourth anniversary of March 1, 2026.

Key Dates

Recommendation

This Form 4 details routine executive compensation in the form of equity grants, which aligns management interests with shareholders but does not provide new fundamental information to alter an investment thesis. It is a standard disclosure and not typically a catalyst for significant price movement.

Keywords

Danaher, DHR, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Stock Options, Equity Grant